Browse by UCL Departments and Centres
![[up]](/style/images/multi_up.png)
Up a levelGroup by: Author | Type
Number of items: 145.
A
Aad, G;
Abbott, B;
Abbott, DC;
Abdinov, O;
Abud, AA;
Abeling, K;
Abhayasinghe, DK;
... Pereira, RA; + view all
(2020)
Search for electroweak production of charginos and sleptons decaying into final states with two leptons and missing transverse momentum in √s=13 TeV pp collisions using the ATLAS detector.
European Physical Journal C
, 80
, Article 123. 10.1140/epjc/s10052-019-7594-6.
|
 |
|
AbdulJabbar, K;
Raza, SEA;
Rosenthal, R;
Jamal-Hanjani, M;
Veeriah, S;
Akarca, A;
Lund, T;
... Yuan, Y; + view all
(2020)
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
Nature Medicine
, 26
pp. 1054-1062.
10.1038/s41591-020-0900-x.
|
|
Abou-Alfa, GK;
Macarulla, T;
Javle, MM;
Kelley, RK;
Lubner, SJ;
Adeva, J;
Cleary, JM;
... Zhu, AX; + view all
(2020)
Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet Oncology
, 21
(6)
pp. 796-807.
10.1016/S1470-2045(20)30157-1.
|
|
Ali, H;
Puccio, I;
Akarca, AU;
Bob, R;
Pomplun, S;
Keong Wong, W;
Gupta, R;
... Marafioti, T; + view all
(2020)
Megakaryocytes, erythropoietic and granulopoietic cells express CAL2 antibody in myeloproliferative neoplasms carrying CALR gene mutations.
International Journal of Experimental Pathology
10.1111/iep.12375.
|
|
|
Almarzouki, A;
Wilson, D;
Ambler, G;
Shakeshaft, C;
Cohen, H;
Yousry, T;
Salman, RA-S;
... Werring, DJ; + view all
(2020)
Sensitivity and specifcity of blood‑fuid levels for oral anticoagulant‑associated intracerebral haemorrhage.
Scientific Reports
, 10
(1)
, Article 15529. 10.1038/s41598-020-72504-7.
|
|
|
Alrasheed, N;
Lee, L;
Ghorani, E;
Henry, JY;
Conde, L;
Chin, M;
Galas-Filipowicz, D;
... Yong, KL; + view all
(2020)
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4⁺PD-1⁺ Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
Clinical Cancer Research
, 26
(13)
pp. 3443-3454.
10.1158/1078-0432.CCR-19-1714.
|
|
Aref, S;
Castleton, AZ;
Bailey, K;
Burt, R;
Dey, A;
Leongamornlert, D;
Mitchell, RJ;
... Fielding, AK; + view all
(2020)
Type-1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
Molecular Therapy
, 28
(4)
pp. 1043-1055.
10.1016/j.ymthe.2020.01.027.
|
|
Ascierto, PA;
Bifulco, C;
Galon, J;
Garbe, C;
Khleif, SN;
McQuade, J;
Odunsi, K;
... Puzanov, I; + view all
(2020)
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019.
Journal for ImmunoTherapy of Cancer
, 8
(2)
, Article e000921. 10.1136/jitc-2020-000921.
|
|
|
Atkin, C;
Iqbal, G;
Planche, T;
Pratt, G;
Yong, K;
Wood, J;
Raynes, K;
... Trial Investigators; + view all
(2020)
Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial.
British Journal of Haematology
10.1111/bjh.17044.
(In press).
|
|
|
Augusto, JB;
Johner, N;
Shah, D;
Nordin, S;
Knott, KD;
Rosmini, S;
Lau, C;
... Namdar, M; + view all
(2020)
The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
European Heart Journal: Cardiovascular Imaging
10.1093/ehjci/jeaa101.
(In press).
|
|
|
Augusto, JB;
Nordin, S;
Vijapurapu, R;
Baig, S;
Bulluck, H;
Castelletti, S;
Alfarih, M;
... Moon, JC; + view all
(2020)
Myocardial Edema, Myocyte Injury, and Disease Severity in Fabry Disease.
Circulation: Cardiovascular Imaging
, 13
(3)
, Article e010171. 10.1161/CIRCIMAGING.119.010171.
|
|
|
Awan, M;
Buriak, I;
Fleck, R;
Fuller, B;
Goltsev, A;
Kerby, J;
Lowdell, M;
... Stacey, GN; + view all
(2020)
Dimethyl sulfoxide: a central player since the dawn of cryobiology, is efficacy balanced by toxicity?
Regenerative Medicine
, 15
(3)
10.2217/rme-2019-0145.
|
|
B
|
Banales, JM;
Marin, JJG;
Lamarca, A;
Rodrigues, PM;
Khan, SA;
Roberts, LR;
Cardinale, V;
... Gores, GJ; + view all
(2020)
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Nature Reviews Gastroenterology & Hepatology
10.1038/s41575-020-0310-z.
(In press).
|
|
|
Banerjee, G;
Ambler, G;
Wilson, D;
Hostettler, IC;
Shakeshaft, C;
Lunawat, S;
Cohen, H;
... CROMIS-2 collaborators, .; + view all
(2020)
Baseline factors associated with early and late death in intracerebral haemorrhage survivors.
European Journal of Neurology
, 27
(7)
pp. 1257-1263.
10.1111/ene.14238.
|
|
|
Banerjee, G;
Chan, E;
Ambler, G;
Wilson, D;
Cipolotti, L;
Shakeshaft, C;
Cohen, H;
... CROMIS‐2 Collaborators, *; + view all
(2020)
Cognitive Impairment Before Atrial Fibrillation-Related Ischemic Events: Neuroimaging and Prognostic Associations.
Journal of the American Heart Association
, 9
(1)
, Article e014537. 10.1161/JAHA.119.014537.
|
|
|
Banerjee, G;
Wilson, D;
Ambler, G;
Hostettler, IC;
Shakeshaft, C;
Cohen, H;
Yousry, T;
... CROMIS-2 collaborators; + view all
(2020)
Longer term stroke risk in intracerebral haemorrhage survivors.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323079.
(In press).
|
|
|
Barry, A;
Apisarnthanarax, S;
O'Kane, GM;
Sapisochin, G;
Beecroft, R;
Salem, R;
Yoon, SM;
... Hawkins, MA; + view all
(2020)
Management of primary hepatic malignancies during the COVID-19 pandemic: recommendations for risk mitigation from a multidisciplinary perspective.
The Lancet Gastroenterology & Hepatology
10.1016/S2468-1253(20)30182-5.
(In press).
|
|
Bekaii-Saab, TS;
Valle, JW;
Cutsem, EV;
Rimassa, L;
Furuse, J;
Ioka, T;
Melisi, D;
... Vogel, A; + view all
(2020)
FIGHT-302: first-line pemigatinib vs gemcitabine plus cisplatin for advanced cholangiocarcinoma with FGFR2 rearrangements.
Future Oncology
10.2217/fon-2020-0429.
(In press).
|
|
|
Best, JG;
Barbato, C;
Ambler, G;
Du, H;
Banerjee, G;
Wilson, D;
Shakeshaft, C;
... Clinical Relevance of Microbleeds in Stroke (CROMIS-2) collabora; + view all
(2020)
Association of enlarged perivascular spaces and anticoagulant-related intracranial hemorrhage.
Neurology
10.1212/WNL.0000000000010788.
(In press).
|
|
|
Beyrouti, R;
Adams, ME;
Benjamin, L;
Cohen, H;
Farmer, SF;
Goh, YY;
Humphries, F;
... Werring, DJ; + view all
(2020)
Characteristics of ischaemic stroke associated with COVID-19.
[Letter].
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323586.
(In press).
|
|
|
Borrello, T;
Tam, CH;
Shafat, M;
Rushworth, S;
Bowles, K;
Bailey, S;
Crabb, S;
... Douglas, L; + view all
(2020)
Synthesis of Carboxamides Tranylcypromine Analogues as LSD1 (KDM1A) Inhibitors for AML.
ChemRxiv: Cambridge, UK.
|
|
Bridgewater, JA;
Pugh, SA;
Maishman, T;
Eminton, Z;
Mellor, J;
Whitehead, A;
Stanton, L;
... New EPOC investigators; + view all
(2020)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial.
The Lancet Oncology
, 21
(3)
pp. 398-411.
10.1016/S1470-2045(19)30798-3.
|
|
|
Bultitude, Will P.;
(2020)
Generating full-length Killer-cell Immunoglobulin-like Receptor (KIR) gene sequences using Third Generation long-amplicon sequencing to assess the impact of KIR polymorphism on Haematopoietic Cell Transplantation outcomes.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Bultitude, WP;
Schellekens, J;
Szydlo, RM;
Anthias, C;
Cooley, SA;
Miller, JS;
Weisdorf, DJ;
... Marsh, SGE; + view all
(2020)
Presence of donor-encoded centromeric KIR B content increases the risk of infectious mortality in recipients of myeloablative, T-cell deplete, HLA-matched HCT to treat AML.
Bone Marrow Transplantation
, 55
pp. 1975-1984.
10.1038/s41409-020-0858-9.
|
|
Burt, Richard James;
(2020)
Defining the role of mesenchymal stromal cells in treatment resistance in acute lymphoblastic leukaemia.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
|
Bustoros, M;
Sklavenitis-Pistofidis, R;
Park, J;
Redd, R;
Zhitomirsky, B;
Dunford, AJ;
Salem, K;
... Ghobrial, IM; + view all
(2020)
Genomic Profiling of Smoldering Multiple Myeloma Identifies Patients at a High Risk of Disease Progression.
Journal of Clinical Oncology
, 38
(21)
pp. 2380-2389.
10.1200/JCO.20.00437.
|
C
|
Cappellini, MD;
Viprakasit, V;
Taher, AT;
Georgiev, P;
Kuo, KHM;
Coates, T;
Voskaridou, E;
... BELIEVE Investigators; + view all
(2020)
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
The New England Journal of Medicine
, 382
(13)
pp. 1219-1231.
10.1056/NEJMoa1910182.
|
|
Chari, A;
Samur, MK;
Martinez-Lopez, J;
Cook, G;
Biran, N;
Yong, KL;
Hungria, VTDM;
... Avet-Loiseau, H; + view all
(2020)
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set.
Blood
, 136
(26)
pp. 3033-3040.
10.1182/blood.2020008150.
|
|
Chavda, SJ;
Pocock, R;
Cheesman, S;
Lee, K-M;
Dowling, E;
Marks, DJB;
Kyriakou, C;
... Popat, R; + view all
(2020)
Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations.
British Journal of Haematology
10.1111/bjh.16889.
(In press).
|
|
|
Chen, LY;
Keddie, S;
Lunn, MP;
Bomsztyk, J;
Vitsaras, E;
Gupta, R;
D'Sa, S;
(2020)
IgM paraprotein-associated peripheral neuropathy: small CD20-positive B-cell clones may predict a monoclonal gammopathy of neurological significance and rituximab responsiveness.
British Journal of Haematology
, 188
(4)
pp. 511-515.
10.1111/bjh.16210.
|
|
Chicca, IJ;
Heaney, JLJ;
Iqbal, G;
Dunn, JA;
Bowcock, S;
Planche, T;
Pratt, G;
... Drayson, MT; + view all
(2020)
Stratifying risk of infection and response to therapy in patients with myeloma: a prognostic study.
Efficacy and Mechanism Evaluation
, 7
(10)
10.3310/eme07100.
|
|
|
Chicca, IJ;
Heaney, JLJ;
Iqbal, G;
Dunn, JA;
Bowcock, S;
Pratt, G;
Yong, KL;
... Drayson, MT; + view all
(2020)
Anti-bacterial antibodies in multiple myeloma patients at disease presentation, in response to therapy and in remission: implications for patient management.
Blood Cancer Journal
, 10
(11)
, Article 114. 10.1038/s41408-020-00370-7.
|
|
|
Chowdary, P;
Hamid, C;
Slatter, D;
Morris, R;
Foley, JH;
Gomez, K;
Brodkin, E;
... McVey, JH; + view all
(2020)
Impaired platelet-dependent thrombin generation associated with thrombocytopenia is improved by prothrombin complex concentrates in vitro.
Research and Practice in Thrombosis and Haemostasis
, 4
(2)
pp. 334-342.
10.1002/rth2.12310.
|
|
|
Clesham, K;
Rao, V;
Bartram, J;
Ancliff, P;
Ghorashian, S;
O'Connor, D;
Pavasovic, V;
... Vora, A; + view all
(2020)
Blinatumomab for infant acute lymphoblastic leukemia.
Blood
, 135
(17)
pp. 1501-1504.
10.1182/blood.2019004008.
|
|
Cohen, H;
Cuadrado, MJ;
Erkan, D;
Duarte-Garcia, A;
Isenberg, DA;
Knight, JS;
Ortel, TL;
... Andrade, D; + view all
(2020)
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends.
Lupus
, 29
(12)
pp. 1571-1593.
10.1177/0961203320950461.
|
|
Cohen, H;
Sayar, Z;
Efthymiou, M;
Gaspar, P;
Richards, T;
Isenberg, D;
(2020)
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome.
The Lancet Haematology
, 7
(8)
e613-e623.
10.1016/S2352-3026(20)30116-2.
|
|
Cohen, OC;
Brodermann, MH;
Blakeney, IJ;
Mahmood, S;
Sachchithanantham, S;
Ravichandran, S;
Law, S;
... Wechalekar, AD; + view all
(2020)
Rapid response to single agent daratumumab is associated with improved progression-free survival in relapsed/refractory AL amyloidosis.
Amyloid
, 27
(3)
pp. 200-205.
10.1080/13506129.2020.1765768.
|
|
Cohen, OC;
Sharpley, F;
Gillmore, JD;
Lachmann, HJ;
Sachchithanantham, S;
Mahmood, S;
Fontana, M;
... Wechalekar, AD; + view all
(2020)
Use of ixazomib, lenalidomide and dexamethasone in patients with relapsed amyloid light‐chain amyloidosis.
British Journal of Haematology
, 189
(4)
pp. 643-649.
10.1111/bjh.16401.
|
|
Comerford, AG;
Lucas, JAM;
Turner, TR;
Marsh, SGE;
Mayor, NP;
(2020)
The novel HLA-C*03:04:01:47 allele sequence identified using Pacific biosciences SMRT sequencing.
HLA: Immune Response Genetics
, 96
(4)
pp. 525-526.
10.1111/tan.14006.
|
|
|
Corrie, PG;
Qian, W;
Basu, B;
Valle, JW;
Falk, S;
Lwuji, C;
Wasan, H;
... Jodrell, DI; + view all
(2020)
Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma.
British Journal of Cancer
10.1038/s41416-020-0846-2.
|
|
|
Crolley, VE;
Hanna, D;
Joharatnam-Hogan, N;
Chopra, N;
Bamac, E;
Desai, M;
Lam, YC;
... Khan, K; + view all
(2020)
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study.
Therapeutic Advances in Medical Oncology
, 12
pp. 1-14.
10.1177/1758835920971147.
|
|
D
|
Dertschnig, S;
Evans, P;
Santos e Sousa, P;
Manzo, T;
Ferrer, IR;
Stauss, HJ;
Bennett, CL;
(2020)
Graft-versus-host disease reduces lymph node display of tissue-restricted self-antigens and promotes autoimmunity.
The Journal of Clinical Investigation
10.1172/JCI133102.
(In press).
|
|
|
Dillon, R;
Hills, RK;
Freeman, SD;
Potter, N;
Jovanovic, J;
Ivey, A;
Kanda, AS;
... Grimwade, D; + view all
(2020)
Molecular MRD status and outcome after transplantation in NPM1 mutated AML: results from the UK NCRI AML17 study.
Blood
, 135
(9)
pp. 680-688.
10.1182/blood.2019002959.
|
|
Dimopoulos, MA;
Leleu, X;
Moreau, P;
Richardson, PG;
Liberati, AM;
Harrison, SJ;
Miles Prince, H;
... Yong, K; + view all
(2020)
Isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma patients with renal impairment: ICARIA-MM subgroup analysis.
Leukemia
10.1038/s41375-020-0868-z.
(In press).
|
|
Duggleby, Richard C;
Tsang, Hoi Pat;
Strange, Kathryn;
McWhinnie, Alasdair;
Lamikanra, Abigail A;
Roberts, David J;
Hernandez, Diana;
... Danby, Robert D; + view all
(2020)
Enumerating regulatory T cells in cryopreserved umbilical cord blood samples using FOXP3 methylation specific quantitative PCR.
PLoS ONE
, 15
(10)
, Article e0240190. 10.1371/journal.pone.0240190.
|
 |
E
|
Enshaei, A;
O'Connor, D;
Bartram, J;
Hancock, J;
Harrison, CJ;
Hough, R;
Samarasinghe, S;
... Moorman, AV; + view all
(2020)
A validated novel continuous prognostic index to deliver stratified medicine in pediatric acute lymphoblastic leukemia.
Blood
, 135
(17)
pp. 1438-1446.
10.1182/blood.2019003191.
|
F
|
Farah, N;
Burt, R;
Ibrahim, AR;
Baker, R;
Kottaridis, PD;
(2020)
Concerns about how to use established minimal residual disease monitoring in the treatment of NPM1-mutant acute myeloid leukaemia (AML) following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic.
British Journal of Haematology
, 190
(4)
E208-E210.
10.1111/bjh.16985.
|
|
Feldt-Rasmussen, U;
Hughes, D;
Sunder-Plassmann, G;
Shankar, S;
Nedd, K;
Olivotto, I;
Ortiz, D;
... Nicholls, K; + view all
(2020)
Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study.
Molecular Genetics and Metabolism
, 131
(1-2)
pp. 219-228.
10.1016/j.ymgme.2020.07.007.
|
|
|
Feriozzi, S;
Linhart, A;
Ramaswami, U;
Kalampoki, V;
Gurevich, A;
Hughes, D;
Fabry Outcome Survey Study Group;
(2020)
Effects of Baseline Left Ventricular Hypertrophy and Decreased Renal Function on Cardiovascular and Renal Outcomes in Patients with Fabry Disease Treated with Agalsidase Alfa: A Fabry Outcome Survey Study.
Clinical Therapeutics
10.1016/j.clinthera.2020.10.007.
(In press).
|
|
|
Fielding, AK;
Goldstone, AH;
(2020)
Acute lymphoblastic leukaemia (ALL) things come to those who wait: 60 years of progress in the treatment of adult ALL.
British Journal of Haematology
, 191
(4)
pp. 558-561.
10.1111/bjh.17166.
|
|
|
Fox, TA;
Troy-Barnes, E;
Kirkwood, AA;
Chan, WY;
Day, JW;
Chavda, SJ;
Kumar, EA;
... Ardeshna, KM; + view all
(2020)
Response to 'Impact of immunosuppression on mortality in critically ill COVID-19 patients'.
British Journal of Haematology
, 191
(3)
pp. 505-506.
10.1111/bjh.17110.
|
|
Fox, TA;
Halsey, R;
Pomplun, S;
Gant, V;
Grandage, V;
Mansour, MR;
Hough, R;
(2020)
Rapid clinical response to adjuvant corticosteroids in chronic disseminated candidiasis complicated by granulomas and persistent fever in acute leukemia patients.
Leukemia & Lymphoma
, 61
(4)
pp. 944-949.
10.1080/10428194.2019.1691198.
|
|
Fox, TA;
Troy-Barnes, E;
Kirkwood, AA;
Chan, WY;
Day, J;
Chavda, SJ;
Kumar, EA;
... Ardeshna, KM; + view all
(2020)
Clinical outcomes and risk factors for severe COVID‐19 infection in patients with haematological disorders receiving chemo‐ or immunotherapy.
British Journal of Haematology
, 191
(2)
pp. 194-206.
10.1111/bjh.17027.
|
G
|
Garbowski, MW;
Bansal, S;
Porter, JB;
Mori, C;
Burckhardt, S;
Hider, RC;
(2020)
Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways.
Haematologica
10.3324/haematol.2020.250803.
(In press).
|
|
Gaspar, P;
Cohen, H;
Isenberg, DA;
(2020)
The assessment of patients with the antiphospholipid antibody syndrome: where are we now?
Rheumatology
, 59
(7)
pp. 1489-1494.
10.1093/rheumatology/keaa172.
|
|
Ghorani, E;
Reading, JL;
Henry, JY;
Massy, MRD;
Rosenthal, R;
Turati, V;
Joshi, K;
... Quezada, SA; + view all
(2020)
The T cell differentiation landscape is shaped by tumour mutations in lung cancer.
Nature Cancer
, 1
(5)
pp. 546-561.
10.1038/s43018-020-0066-y.
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study.
Frontiers in Pharmacology
, 11
, Article 1308. 10.3389/fphar.2020.01308.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.
Frontiers in Pharmacology
, 11
, Article 571066. 10.3389/fphar.2020.571066.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity.
Frontiers in Pharmacology
, 11
, Article 209. 10.3389/fphar.2020.00209.
|
|
|
Goswami, P;
Oliva, EN;
Ionova, T;
Else, R;
Kell, J;
Fielding, AK;
Jennings, DM;
... Salek, S; + view all
(2020)
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study.
Therapeutic Advances in Hematology
, 11
pp. 1-14.
10.1177/2040620720955002.
|
|
|
Gupta, R;
Gant, VA;
Williams, B;
Enver, T;
(2020)
Increased Complement Receptor-3 levels in monocytes and granulocytes distinguish COVID-19 patients with pneumonia from those with mild symptoms.
International Journal of Infectious Diseases
10.1016/j.ijid.2020.08.004.
(In press).
|
|
|
Gupta, R;
Turati, V;
Brian, D;
Thrussel, C;
Wilbourn, B;
May, G;
Enver, T;
(2020)
Nov/CCN3 Enhances Cord Blood Engraftment by Rapidly Recruiting Latent Human Stem Cell Activity.
Cell Stem Cell
10.1016/j.stem.2020.02.012.
(In press).
|
H
|
Hockings, C;
Gohil, S;
Dowse, R;
Hoade, Y;
Mansour, MR;
Gale, RE;
Linch, DC;
... Payne, EM; + view all
(2020)
In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation.
British Journal of Haematology
, 188
(4)
e53-e57.
10.1111/bjh.16322.
|
|
Hoffman, HI;
Guo, JA;
Hawkins, MA;
Bridgewater, JA;
Wo, JY;
Hong, TS;
Hwang, WL;
(2020)
Silver Linings: An Opportunity to Improve Clinical Paradigms After the COVID-19 Pandemic.
JCO Oncology Practice
10.1200/OP.20.00335.
(In press).
|
|
Hostettler, IC;
Morton, MJ;
Ambler, G;
Kazmi, N;
Gaunt, T;
Wilson, D;
Shakeshaft, C;
... CROMIS-2 collaborators; + view all
(2020)
Haptoglobin genotype and outcome after spontaneous intracerebral haemorrhage.
Journal of Neurology, Neurosurgery and Psychiatry
, 91
(3)
pp. 298-304.
10.1136/jnnp-2019-321774.
|
|
|
Hughes, DA;
Aguiar, P;
Deegan, PB;
Ezgu, F;
Frustaci, A;
Lidove, O;
Linhart, A;
... Feriozzi, S; + view all
(2020)
Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative.
BMJ Open
, 10
(10)
, Article e035182. 10.1136/bmjopen-2019-035182.
|
|
|
Hutachok, N;
Angkasith, P;
Chumpun, C;
Fucharoen, S;
Mackie, IJ;
Porter, JB;
Srichairatanakool, S;
(2020)
Anti-Platelet Aggregation and Anti-Cyclooxygenase Activities for a Range of Coffee Extracts (Coffea arabica).
Molecules
, 26
, Article 10. 10.3390/molecules26010010.
|
|
I
|
Iyer, RV;
Acquisto, SG;
Bridgewater, JA;
Choti, MA;
Hong, TS;
Kis, B;
Mead, PA;
... Valle, JW; + view all
(2020)
Guidelines for Management of Urgent Symptoms in Patients with Cholangiocarcinoma and Biliary Stents or Catheters Using the Modified RAND/UCLA Delphi Process.
Cancers
, 12
(9)
, Article 2375. 10.3390/cancers12092375.
|
|
J
|
Joharatnam-Hogan, N;
Hochhauser, D;
Shiu, K-K;
Rush, H;
Crolley, V;
Wilson, W;
Sharma, A;
... Khan, K; + view all
(2020)
Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience.
Therapeutic Advances in Medical Oncology
pp. 1-9.
10.1177/1758835920956803.
|
|
Joharatnam-Hogan, N;
Wilson, W;
Shiu, KK;
Fusai, GK;
Davidson, B;
Hochhauser, D;
Bridgewater, J;
(2020)
Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes—The University College London Hospital (UCLH) Experience.
Cancers
, 12
(12)
, Article 3545. 10.3390/cancers12123545.
|
|
|
Jones, CM;
Radhakrishna, G;
Aitken, K;
Bridgewater, J;
Corrie, P;
Eatock, M;
Goody, R;
... Mukherjee, S; + view all
(2020)
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position.
British Journal of Cancer
, 123
pp. 709-713.
10.1038/s41416-020-0980-x.
|
K
|
Kalam, S;
Beale, R;
Hughes, D;
Kulasekararaj, A;
Srirangalingam, U;
(2020)
Coombs-positive Paroxysmal Nocturnal Haemoglobinuria.
Oxford Medical Case Reports
(3)
, Article omz125. 10.1093/omcr/omz125.
|
|
|
Kantaris, X;
Shevlin, M;
Porter, J;
Myers, L;
(2020)
Development of the Thalassaemia Adult Life Index (ThALI).
Health and Quality of Life Outcomes
, 18
, Article 180. 10.1186/s12955-020-01437-6.
|
|
|
Karda, R;
Rahim, AA;
Wong, AMS;
Suff, N;
Diaz, JA;
Perocheau, DP;
Tijani, M;
... Waddington, SN; + view all
(2020)
Generation of light-producing somatic-transgenic mice using adeno-associated virus vectors.
Scientific Reports
, 10
(1)
, Article 2121. 10.1038/s41598-020-59075-3.
|
|
|
Keddie, S;
Foldes, D;
Caimari, F;
Baldeweg, SE;
Bomsztyk, J;
Ziff, OJ;
Fehmi, J;
... Lunn, MP; + view all
(2020)
Clinical characteristics, risk factors, and outcomes of POEMS syndrome: A longitudinal cohort study.
Neurology
, 95
(3)
e268-e279.
10.1212/WNL.0000000000009940.
|
|
Kelley, RK;
Bridgewater, J;
Gores, GJ;
Zhu, AX;
(2020)
Systemic therapies for intrahepatic cholangiocarcinoma.
Journal of Hepatology
, 72
(2)
pp. 353-363.
10.1016/j.jhep.2019.10.009.
|
|
Koutoukidis, DA;
Land, J;
Hackshaw, A;
Heinrich, M;
McCourt, O;
Beeken, RJ;
Philpott, S;
... Yong, KL; + view all
(2020)
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
British Journal of Cancer
10.1038/s41416-020-0866-y.
(In press).
|
|
|
Koutoukidis, DA;
Land, J;
Hackshaw, A;
Heinrich, M;
McCourt, O;
Beeken, RJ;
Philpott, S;
... Yong, KL; + view all
(2020)
Fatigue, quality of life and physical fitness following an exercise intervention in multiple myeloma survivors (MASCOT): an exploratory randomised Phase 2 trial utilising a modified Zelen design.
British Journal of Cancer
10.1038/s41416-020-0866-y.
(In press).
|
|
L
|
Lai, AG;
Pasea, L;
Banerjee, A;
Hall, G;
Denaxas, S;
Chang, WH;
Katsoulis, M;
... Hemingway, H; + view all
(2020)
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study.
BMJ Open
, 10
(11)
, Article e043828. 10.1136/bmjopen-2020-043828.
|
|
|
Lamarca, A;
Edeline, J;
McNamara, MG;
Hubner, RA;
Nagino, M;
Bridgewater, J;
Primrose, J;
(2020)
Current standards and future perspectives in adjuvant treatment for biliary tract cancers.
Cancer Treatment Reviews
, 84
, Article 101936. 10.1016/j.ctrv.2019.101936.
|
|
Land, J;
McCourt, O;
Heinrich, M;
Beeken, RJ;
Koutoukidis, DA;
Paton, B;
Yong, K;
... Fisher, A; + view all
(2020)
The adapted Zelen was a feasible design to trial exercise in myeloma survivors.
Journal of Clinical Epidemiology
, 125
pp. 76-83.
10.1016/j.jclinepi.2020.04.004.
|
|
|
Latifoltojar, A;
Duncan, MKJ;
Klusmann, M;
Sidhu, H;
Bainbridge, A;
Neriman, D;
Fraioli, F;
... Punwani, S; + view all
(2020)
Whole Body 3.0 T Magnetic Resonance Imaging in Lymphomas: Comparison of Different Sequence Combinations for Staging Hodgkin's and Diffuse Large B Cell Lymphomas.
Journal of Personalized Medicine
, 10
(4)
, Article 284. 10.3390/jpm10040284.
|
|
|
Lecat, CSY;
Besley, C;
Hough, RE;
Khwaja, A;
Furness, C;
Marks, DI;
Fielding, AK;
(2020)
Inotuzumab ozogamicin versus FLAG-Ida in the treatment of relapsed or refractory B-cell acute lymphoblastic leukemia – real-world resource use data.
Leukemia & Lymphoma
, 61
(2)
pp. 491-493.
10.1080/10428194.2019.1672057.
|
|
Leen, G;
Stein, JE;
Robinson, J;
Maldonado Torres, H;
Marsh, SGE;
(2020)
The HLA diversity of the Anthony Nolan register.
HLA
, 97
(1)
pp. 15-29.
10.1111/tan.14127.
|
|
|
Leon, TE;
Rapoz-D'Silva, T;
Bertoli, C;
Rahman, S;
Magnussen, M;
Philip, B;
Farah, N;
... Mansour, MR; + view all
(2020)
EZH2 deficient T-cell acute lymphoblastic leukemia is sensitized to CHK1 inhibition through enhanced replication stress.
Cancer Discovery
, 10
(7)
10.1158/2159-8290.CD-19-0789.
|
|
Leong, S;
Inglott, S;
Papaleonidopoulou, F;
Orfinada, K;
Ancliff, P;
Bartram, J;
Carpenter, B;
... O'Connor, D; + view all
(2020)
CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy.
Blood Advances
, 4
(19)
pp. 4665-4668.
10.1182/bloodadvances.2020002502.
|
|
Linch, D;
(2020)
Developments over the last 60 years in diffuse large B-cell lymphomas.
British Journal of Haematology
, 191
(4)
pp. 552-557.
10.1111/bjh.17154.
|
|
|
Linch, DC;
Hills, RK;
Burnett, AK;
Russell, N;
Gale, RE;
(2020)
Analysis of the clinical impact of NPM1 mutant allele burden in a large cohort of younger adult patients with acute myeloid leukaemia.
British Journal of Haematology
, 188
(6)
pp. 852-859.
10.1111/bjh.16239.
|
|
Linhart, A;
Germain, DP;
Olivotto, I;
Akhtar, MM;
Anastasakis, A;
Hughes, D;
Namdar, M;
... Elliott, P; + view all
(2020)
An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease.
European Journal of Heart Failure
, 22
(7)
pp. 1076-1096.
10.1002/ejhf.1960.
|
|
|
Litchfield, K;
Reading, JL;
Lim, EL;
Xu, H;
Liu, P;
Al-Bakir, M;
Wong, YNS;
... Swanton, C; + view all
(2020)
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.
Nature Communications
, 11
, Article 3800. 10.1038/s41467-020-17526-5.
|
|
|
Litchfield, K;
Stanislaw, S;
Spain, L;
Gallegos, LL;
Rowan, A;
Schnidrig, D;
Rosenbaum, H;
... Turajlic, S; + view all
(2020)
Representative Sequencing: Unbiased Sampling of Solid Tumor Tissue.
Cell Reports
, 31
(5)
p. 107550.
10.1016/j.celrep.2020.107550.
|
|
Loke, J;
Lowe, DM;
Miller, LJ;
Morton, S;
Roy, NBA;
Sekhar, M;
Stanworth, SJ;
(2020)
Supportive care in the management of patients with acute myeloid leukaemia: where are the research needs?
British Journal of Haematology
10.1111/bjh.16708.
(In press).
|
|
|
López, S;
Lim, EL;
Horswell, S;
Haase, K;
Huebner, A;
Dietzen, M;
Mourikis, TP;
... McGranahan, N; + view all
(2020)
Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.
Nature Genetics
, 52
(3)
pp. 283-293.
10.1038/s41588-020-0584-7.
|
M
|
Mackie, I;
Mancini, I;
Muia, J;
Kremer Hovinga, J;
Nair, S;
Machin, S;
Baker, R;
(2020)
International Council for Standardization in Haematology (ICSH) recommendations for laboratory measurement of ADAMTS13.
International Journal of Laboratory Hematology
, 42
(6)
pp. 685-696.
10.1111/ijlh.13295.
|
|
|
Marin, JJG;
Prete, MG;
Lamarca, A;
Tavolari, S;
Landa-Magdalena, A;
Brandi, G;
Segatto, O;
... Braconi, C; + view all
(2020)
Current and novel therapeutic opportunities for systemic therapy in biliary cancer.
British Journal of Cancer
, 123
pp. 1047-1059.
10.1038/s41416-020-0987-3.
|
|
Marshall, A;
Kasturiarachchi, J;
Datta, P;
Guo, Y;
Deltcheva, E;
James, C;
Brown, J;
... Nimmo, R; + view all
(2020)
Mir142 loss unlocks IDH2R140-dependent leukemogenesis through antagonistic regulation of HOX genes.
Scientific Reports
, 10
, Article 19390. 10.1038/s41598-020-76218-8.
|
|
Mc Lernon, S;
Schwarz, G;
Wilson, D;
Ambler, G;
Goodwin, R;
Shakeshaft, C;
Cohen, H;
... CROMIS-2 Collaborators; + view all
(2020)
Association between critical care admission and 6-month functional outcome after spontaneous intracerebral haemorrhage.
Journal of the Neurological Sciences
, 418
, Article 117141. 10.1016/j.jns.2020.117141.
|
|
McCourt, O;
Fisher, A;
Ramdharry, G;
Roberts, AL;
Land, J;
Rabin, N;
Yong, K;
(2020)
PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple myeloma.
BMJ Open
, 10
(1)
, Article e033176. 10.1136/bmjopen-2019-033176.
|
|
|
McMillan, AK;
Phillips, EH;
Kirkwood, AA;
Barrans, S;
Burton, C;
Rule, S;
Patmore, R;
... Linch, DC; + view all
(2020)
Favourable outcomes for high-risk diffuse large B-cell lymphoma (IPI 3–5) treated with front-line R-CODOX-M/R-IVAC chemotherapy: results of a phase 2 UK NCRI trial.
Annals of Oncology
10.1016/j.annonc.2020.05.016.
(In press).
|
|
|
McNamara, MG;
Lopes, A;
Wasan, H;
Malka, D;
Goldstein, D;
Shannon, J;
Okusaka, T;
... Valle, JW; + view all
(2020)
Landmark survival analysis and impact of anatomic origin in prospective clinical trials of biliary tract cancer.
Journal of Hepatology
, 73
(5)
pp. 1109-1117.
10.1016/j.jhep.2020.05.014.
|
|
Mehta, A;
Rivero-Arias, O;
Abdelwahab, M;
Campbell, S;
McMillan, A;
Rolfe, MJ;
Bright, JR;
(2020)
Scoring system to facilitate diagnosis of Gaucher disease.
Internal Medicine Journal
, 50
(12)
pp. 1538-1546.
10.1111/imj.14942.
|
|
|
Miles, A;
Evans, RE;
Halligan, S;
Beare, S;
Bridgewater, J;
Goh, V;
Janes, SM;
... STREAMLINE investigators; + view all
(2020)
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer.
Journal of Medical Imaging and Radiation Oncology
10.1111/1754-9485.13038.
(In press).
|
|
|
Moreau, P;
Dimopoulos, MA;
Yong, K;
Mikhael, J;
Risse, M-L;
Asset, G;
Martin, T;
(2020)
Isatuximab plus carfilzomib/dexamethasone versus carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma: IKEMA Phase III study design.
Future Oncology
, 16
(2)
pp. 4347-4358.
10.2217/fon-2019-0431.
|
|
|
Mullin, S;
Stokholm, MG;
Hughes, D;
Mehta, A;
Parbo, P;
Hinz, R;
Pavese, N;
... Schapira, AH; + view all
(2020)
Brain Microglial Activation Increased in Glucocerebrosidase (GBA) Mutation Carriers without Parkinson's disease.
Movement Disorders
10.1002/mds.28375.
|
|
N
|
Nannini, F;
Parekh, F;
Wawrzyniecka, P;
Mekkaoui, L;
Righi, M;
Dastjerdi, FV;
Yeung, J;
... Pule, M; + view all
(2020)
A primer set for the rapid isolation of scFv fragments against cell surface antigens from immunised rats.
Scientific Reports
, 10
, Article 19168. 10.1038/s41598-020-76069-3.
|
|
|
Nathwani, AC;
Tuddenham, EGD;
(2020)
Haemophilia, the journey in search of a cure. 1960–2020.
British Journal of Haematology
, 191
(4)
pp. 573-578.
10.1111/bjh.17155.
|
O
|
Ogunlade, O;
Stowe, C;
Jathoul, A;
Kalber, T;
Lythgoe, MF;
Beard, P;
Pule, M;
(2020)
In vivo photoacoustic imaging of a nonfluorescent E2 crimson genetic reporter in mammalian tissues.
Journal of Biomedical Optics
, 25
(04)
, Article 046004. 10.1117/1.jbo.25.4.046004.
|
|
|
Orf, K;
Rogosic, S;
Dexter, D;
Ancliff, P;
Badle, S;
Brierley, J;
Cheng, D;
... Bartram, J; + view all
(2020)
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.
British Journal of Haematology
, 190
(5)
E274-E276.
10.1111/bjh.17014.
|
P
|
Paradee, N;
Utama-Ang, N;
Uthaipibull, C;
Porter, JB;
Garbowski, MW;
Srichairatanakool, S;
(2020)
Extracts of Thai Perilla frutescens nutlets attenuate tumour necrosis factor-α-activated generation of microparticles, ICAM-1 and IL-6 in human endothelial cells.
Bioscience Reports
, 40
(5)
, Article BSR20192110. 10.1042/BSR20192110.
|
|
|
Pastores, GM;
Hughes, DA;
(2020)
Lysosomal Acid Lipase Deficiency: Therapeutic Options.
Drug Design, Development and Therapy
, 2020
(14)
pp. 591-601.
10.2147/DDDT.S149264.
|
|
|
Patrick, PS;
Kolluri, KK;
Zaw Thin, M;
Edwards, A;
Sage, EK;
Sanderson, T;
Weil, BD;
... Kalber, TL; + view all
(2020)
Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with ⁸⁹Zr-oxine PET-CT.
Stem Cell Research & Therapy
, 11
, Article 256. 10.1186/s13287-020-01770-z.
|
|
|
Pennycuick, A;
Teixeira, VH;
AbdulJabbar, K;
Raza, SEA;
Lund, T;
Akarca, AU;
Rosenthal, R;
... Janes, SM; + view all
(2020)
Immune surveillance in clinical regression of pre-invasive squamous cell lung cancer.
Cancer Discovery
, 10
(10)
pp. 1489-1499.
10.1158/2159-8290.CD-19-1366.
|
|
Popat, R;
Warcel, D;
O'Nions, J;
Cowley, A;
Smith, S;
Tucker, WR;
Yong, K;
(2020)
Characterization of response and corneal events with extended follow-up after belantamab mafodotin (GSK2857916) monotherapy for patients with relapsed multiple myeloma: a case series from the first-time-in-human clinical trial.
Haematologica
, 105
(5)
E261-E263.
10.3324/haematol.2019.235937.
|
|
|
Porter, JB;
(2020)
Iron Through the Prism of Haematology.
British Journal of Haematology
, 191
(4)
pp. 587-592.
10.1111/bjh.17164.
|
|
|
Prommaban, A;
Utama-Ang, N;
Chaikitwattana, A;
Uthaipibull, C;
Porter, JB;
Srichairatanakool, S;
(2020)
Phytosterol, Lipid and Phenolic Composition, and Biological Activities of Guava Seed Oil.
Molecules
, 25
(11)
, Article 2474. 10.3390/molecules25112474.
|
|
|
Pugh, G;
Petrella, A;
Pabary, A;
Cross, A;
Hough, R;
Soanes, L;
Sabiston, C;
(2020)
Health Professionals' Views on Lifestyle Advice Delivery to Teenage and Young Adult Cancer Patients: A Qualitative Study.
Cancer Nursing
10.1097/NCC.0000000000000906.
(In press).
|
R
|
Rao, S;
Sclafani, F;
Eng, C;
Adams, RA;
Guren, MG;
Sebag-Montefiore, D;
Benson, A;
... Cunningham, D; + view all
(2020)
International Rare Cancers Initiative Multicenter Randomized Phase II Trial of Cisplatin and Fluorouracil Versus Carboplatin and Paclitaxel in Advanced Anal Cancer: InterAAct.
Journal of Clinical Oncology
, 38
(22)
pp. 2510-2518.
10.1200/JCO.19.03266.
|
|
Rio-Machin, A;
Vulliamy, T;
Hug, N;
Walne, A;
Tawana, K;
Cardoso, S;
Ellison, A;
... Dokal, I; + view all
(2020)
The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants.
Nature Communications
, 11
, Article 1044. 10.1038/s41467-020-14829-5.
|
|
|
Robertson, NJ;
Meehan, C;
Martinello, KA;
Avdic-Belltheus, A;
Boggini, T;
Mutshiya, T;
Lingam, I;
... Lowdell, MW; + view all
(2020)
Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia.
Cytotherapy
10.1016/j.jcyt.2020.10.005.
(In press).
|
|
S
|
Sabbah, S;
Liew, A;
Brooks, AM;
Kundu, R;
Reading, JL;
Flatt, A;
Counter, C;
... Tree, TIM; + view all
(2020)
Autoreactive T cell profiles are altered following allogeneic islet transplantation with alemtuzumab induction and re‐emerging phenotype is associated with graft function.
American Journal of Transplantation
10.1111/ajt.16285.
(In press).
|
|
|
Sabry, M;
Lowdell, MW;
(2020)
Killers at the crossroads: The use of innate immune cells in adoptive cellular therapy of cancer.
Stem Cells Translational Medicine
10.1002/sctm.19-0423.
(In press).
|
|
|
Schreiber, K;
Sciascia, S;
Bruce, IN;
Giles, I;
Cuadrado, MJ;
Cohen, H;
Gordon, C;
... Hunt, BJ; + view all
(2020)
Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians.
The Lancet Rheumatology
10.1016/S2665-9913(20)30382-9.
(In press).
|
|
|
Sekhar, M;
Jadhav, S;
(2020)
Why stay? Resilience in haemophilia physicians in the 1980s.
Haemophilia
, 26
(3)
pp. 401-408.
10.1111/hae.13967.
|
|
Shafat, MS;
Mehra, V;
Peggs, KS;
Roddie, C;
(2020)
Cellular Therapeutic Approaches to Cytomegalovirus Infection Following Allogeneic Stem Cell Transplantation.
Frontiers in Immunology
, 11
, Article 1694. 10.3389/fimmu.2020.01694.
|
|
|
Shah, V;
Sherborne, AL;
Johnson, DC;
Ellis, S;
Price, A;
Chowdhury, F;
Kendall, J;
... on behalf of NCRI Haematology Clinical Studies Group; + view all
(2020)
Predicting ultrahigh risk multiple myeloma by molecular profiling:
an analysis of newly diagnosed transplant eligible myeloma XI trial
patients.
Leukemia
10.1038/s41375-020-0750-z.
|
|
|
Sharpley, FA;
De-Silva, D;
Mahmood, S;
Sachchithanantham, S;
Ramsay, I;
Garcia Mingo, A;
Worthington, S;
... D Wechalekar, A; + view all
(2020)
Cytomegalovirus reactivation after bortezomib treatment for multiple myeloma and light chain amyloidosis.
European Journal of Haematology
, 104
(3)
pp. 230-235.
10.1111/ejh.13366.
|
|
Sia, KC;
Fu, ZY;
Calne, RY;
Nathwani, AC;
Lee, KO;
Gan, SU;
(2020)
Modification of a Constitutive to Glucose-Responsive Liver-Specific Promoter Resulted in Increased Efficacy of Adeno-Associated Virus Serotype 8-Insulin Gene Therapy of Diabetic Mice.
Cells
, 9
(11)
, Article 2474. 10.3390/cells9112474.
|
|
|
Slyper, M;
Porter, CBM;
Ashenberg, O;
Waldman, J;
Drokhlyansky, E;
Wakiro, I;
Smillie, C;
... Regev, A; + view all
(2020)
A single-cell and single-nucleus RNA-Seq toolbox for fresh and frozen human tumors.
Nature Medicine
, 26
pp. 792-802.
10.1038/s41591-020-0844-1.
|
|
|
Słabicki, M;
Kozicka, Z;
Petzold, G;
Li, Y-D;
Manojkumar, M;
Bunker, RD;
Donovan, KA;
... Ebert, BL; + view all
(2020)
The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K.
Nature
, 585
(7824)
pp. 293-297.
10.1038/s41586-020-2374-x.
|
|
Solomon, I;
Amann, M;
Goubier, A;
Vargas, FA;
Zervas, D;
Qing, C;
Henry, JY;
... Quezada, SA; + view all
(2020)
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity.
Nature Cancer
, 1
(12)
pp. 1153-1166.
10.1038/s43018-020-00133-0.
|
|
|
Straathof, K;
Flutter, B;
Wallace, R;
Jain, N;
Loka, T;
Depani, S;
Wright, G;
... Anderson, J; + view all
(2020)
Anti-tumor activity without on-target off-tumor toxicity of GD2-Chimeric Antigen Receptor T cells in patients with neuroblastoma.
Science Translational Medicine
, 12
(571)
, Article eabd6169. 10.1126/scitranslmed.abd6169.
|
T
|
Teachey, DT;
O'Connor, D;
(2020)
How I treat newly diagnosed T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma in children.
Blood
, 135
(3)
pp. 159-166.
10.1182/blood.2019001557.
|
|
Telfer, P;
De la Fuente, J;
Sohal, M;
Brown, R;
Eleftheriou, P;
Roy, N;
Piel, FB;
... Layton, DM; + view all
(2020)
Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients.
Haematologica
, 105
(11)
pp. 2651-2654.
10.3324/haematol.2020.259440.
|
|
U
|
Ulivi, L;
Kanber, B;
Prados, F;
Davagnanam, I;
Merwick, A;
Chan, E;
Williams, F;
... Werring, DJ; + view all
(2020)
White matter integrity correlates with cognition and disease severity in Fabry disease.
Brain
, 143
(11)
pp. 3331-3342.
10.1093/brain/awaa282.
|
|
Ulivi, L;
Squitieri, M;
Cohen, H;
Cowley, P;
Werring, DJ;
(2020)
Cerebral venous thrombosis: a practical guide.
Practical Neurology
, 20
(5)
pp. 356-367.
10.1136/practneurol-2019-002415.
|
V
|
van der Veen, SJ;
Vlietstra, WJ;
van Dussen, L;
van Kuilenburg, ABP;
Dijkgraaf, MGW;
Lenders, M;
Brand, E;
... Langeveld, M; + view all
(2020)
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease.
International Journal of Molecular Sciences
, 21
(16)
, Article 5784. 10.3390/ijms21165784.
|
|
|
Vijapurapu, R;
Baig, S;
Nordin, S;
Augusto, JB;
Price, AM;
Wheeldon, N;
Lewis, N;
... Steeds, RP; + view all
(2020)
Longitudinal Assessment of Cardiac Involvement in Fabry Disease Using Cardiovascular Magnetic Resonance Imaging.
JACC: Cardiovascular Imaging
, 13
(8)
pp. 1850-1852.
10.1016/j.jcmg.2020.03.004.
|
|
Vila Cuenca, M;
Marchi, G;
Barqué, A;
Esteban-Jurado, C;
Marchetto, A;
Giorgetti, A;
Chelban, V;
... Sanchez, M; + view all
(2020)
Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
International Journal of Molecular Sciences
, 21
(7)
, Article 2374. 10.3390/ijms21072374.
|
|
W
|
Wanner, C;
Feldt-Rasmussen, U;
Jovanovic, A;
Linhart, A;
Yang, M;
Ponce, E;
Brand, E;
... Ortiz, A; + view all
(2020)
Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis.
ESC Heart Failure
, 7
(3)
pp. 825-834.
10.1002/ehf2.12647.
|
|
|
Wilson, AJ;
Troy-Barnes, E;
Subhan, M;
Clark, F;
Gupta, R;
Fielding, AK;
Kottaridis, P;
... Khwaja, A; + view all
(2020)
Successful remission induction therapy with gilteritinib in a patient with de novo FLT3-mutated acute myeloid leukaemia and severe COVID-19.
[Letter].
British Journal of Haematology
, 190
(4)
e189-e191.
10.1111/bjh.16962.
|
Y
|
Yip, HM;
Yong, K;
De-Silva, D;
Rabin, N;
(2020)
Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma.
Hematology/Oncology and Stem Cell Therapy
10.1016/j.hemonc.2020.01.001.
(In press).
|
|
Z
|
Zuily, S;
Cohen, H;
Isenberg, D;
Woller, SC;
Crowther, M;
Dufrost, V;
Wahl, D;
... Devreese, KMJ; + view all
(2020)
Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
J Thromb Haemost
, 18
(9)
pp. 2126-2137.
10.1111/jth.14935.
|
|
Zuily, S;
Clerc-Urmes, I;
Bauman, C;
Andrade, D;
Sciascia, S;
Pengo, V;
Tektonidou, MG;
... Erkan, D; + view all
(2020)
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Lupus
, 29
(11)
pp. 1353-1363.
10.1177/0961203320940776.
|
|
|
Zwi-Dantsis, L;
Winter, CW;
Kauscher, U;
Ferrini, A;
Wang, B;
Whittaker, TE;
Hood, SR;
... Stevens, MM; + view all
(2020)
Highly purified extracellular vesicles from human cardiomyocytes demonstrate preferential uptake by human endothelial cells.
Nanoscale
10.1039/d0nr04278a.
(In press).
|
|
Ś
|
Śledzińska, A;
Vila de Mucha, M;
Bergerhoff, K;
Hotblack, A;
Demane, DF;
Ghorani, E;
Akarca, AU;
... Quezada, SA; + view all
(2020)
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4⁺ T Cells.
Immunity
, 52
(1)
151-166.e6.
10.1016/j.immuni.2019.12.007.
|
